RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Clinigen Group Stock

Clinigen Group Revenue 2024

Clinigen Group Revenue

624.4 M GBP

Ticker

CLIN.L

ISIN

GB00B89J2419

In 2024, Clinigen Group's sales reached 624.4 M GBP, a 5.17% difference from the 593.7 M GBP sales recorded in the previous year.

The Clinigen Group Revenue history

YEARREVENUE (undefined GBP)GROSS MARGIN (%)
2026e653.5830,28
2025e643.1930,77
2024e624.431,69
2023e593.733,33
2022e534.9536,99
2021523.637,80
2020466.743,95
2019456.939,90
2018381.236,39
2017302.340,59
2016339.929,63
2015184.3629,10
2014126.632,54
2013122.628,63
201282.135,32
20113544,29
201021.331,92

Clinigen Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Clinigen Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Clinigen Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Clinigen Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Clinigen Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Clinigen Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Clinigen Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Clinigen Group’s growth potential.

Clinigen Group Revenue, EBIT and net profit per share

DateClinigen Group RevenueClinigen Group EBITClinigen Group Net Income
2026e653.58 M undefined129.53 M undefined105.95 M undefined
2025e643.19 M undefined127.61 M undefined96.52 M undefined
2024e624.4 M undefined124.2 M undefined88.82 M undefined
2023e593.7 M undefined114.92 M undefined81.09 M undefined
2022e534.95 M undefined107.38 M undefined73.71 M undefined
2021523.6 M undefined58.5 M undefined30.3 M undefined
2020466.7 M undefined69.6 M undefined13.7 M undefined
2019456.9 M undefined58 M undefined5.2 M undefined
2018381.2 M undefined49.7 M undefined27.4 M undefined
2017302.3 M undefined44.8 M undefined3.8 M undefined
2016339.9 M undefined32.3 M undefined13.5 M undefined
2015184.36 M undefined26.98 M undefined5.69 M undefined
2014126.6 M undefined23.3 M undefined16.2 M undefined
2013122.6 M undefined14.6 M undefined11.3 M undefined
201282.1 M undefined10.5 M undefined6.6 M undefined
201135 M undefined7.1 M undefined4.3 M undefined
201021.3 M undefined1.2 M undefined900,000 undefined

Clinigen Group stock margins

The Clinigen Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Clinigen Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Clinigen Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Clinigen Group's sales revenue. A higher gross margin percentage indicates that the Clinigen Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Clinigen Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Clinigen Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Clinigen Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Clinigen Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Clinigen Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Clinigen Group Margin History

Clinigen Group Gross marginClinigen Group Profit marginClinigen Group EBIT marginClinigen Group Profit margin
2026e37.8 %19.82 %16.21 %
2025e37.8 %19.84 %15.01 %
2024e37.8 %19.89 %14.22 %
2023e37.8 %19.36 %13.66 %
2022e37.8 %20.07 %13.78 %
202137.8 %11.17 %5.79 %
202043.95 %14.91 %2.94 %
201939.9 %12.69 %1.14 %
201836.39 %13.04 %7.19 %
201740.59 %14.82 %1.26 %
201629.63 %9.5 %3.97 %
201529.1 %14.63 %3.08 %
201432.54 %18.4 %12.8 %
201328.63 %11.91 %9.22 %
201235.32 %12.79 %8.04 %
201144.29 %20.29 %12.29 %
201031.92 %5.63 %4.23 %

Clinigen Group Aktienanalyse

What does Clinigen Group do?

The Clinigen Group PLC is a global pharmaceutical company specializing in the provision of rare disease and hard-to-treat disease treatments. The company was founded in 2010 with the aim of quickly and efficiently providing access to life-saving medicines for patients. However, the history of Clinigen Group goes back further. The company has its roots in Besse Medical, an American drug distributor. In 2004, Clinigen acquired Besse Medical, followed by six more distributors in the US and Europe in the following years. These acquisitions formed the foundation for the current business model. The Clinigen Group's business model is based on three pillars. The first pillar is the "Clinigen Specialty Pharmaceuticals" sector, where the company manufactures and distributes life-saving drugs for severely ill patients worldwide. The second pillar is the "Unlicensed Medicines" business, which allows patients access to unlicensed medicines that are urgently needed in specific cases. Clinigen works with pharmaceutical companies and regulatory authorities to provide these medicines within a certain framework. The third pillar is the "Clinical Trials Supply" department, which supports and streamlines clinical studies by providing medicines and services. Overall, Clinigen offers a variety of products and services, all aimed at securing access to life-saving medicines for patients. These include drugs for the treatment of cancer, infections, autoimmune diseases, neurological diseases, and rare diseases. In addition, Clinigen also offers specialized logistics and distribution services to ensure that medicines reach patients quickly and efficiently. Today, Clinigen Group is a global company headquartered in the UK with offices in North America, Europe, and Asia. The company employs over 1,000 people and works with a variety of pharmaceutical companies and regulatory authorities. An important focus is on the development of new treatment options and therapies for rare and hard-to-treat diseases. Overall, Clinigen Group has established itself as an important player in the pharmaceutical and healthcare industry. The company offers a unique business model and a wide range of products and services to secure access to life-saving medicines for patients worldwide. With its focus on innovation and collaboration with other companies and authorities, Clinigen is committed to ensuring that patients receive quick and efficient access to the medicines they need. Clinigen Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Clinigen Group's Sales Figures

The sales figures of Clinigen Group originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Clinigen Group’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Clinigen Group's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Clinigen Group’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Clinigen Group stock

How much revenue did Clinigen Group generate this year?

Clinigen Group has achieved a revenue of 624.4 M GBP this year.

How much was the turnover of the company Clinigen Group compared to the previous year?

The revenue of Clinigen Group has increased by 5.17% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Clinigen Group?

The revenue of Clinigen Group is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Clinigen Group measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Clinigen Group so important for investors?

The revenue of Clinigen Group is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Clinigen Group pay?

Over the past 12 months, Clinigen Group paid a dividend of 0.08 GBP . This corresponds to a dividend yield of about 0.82 %. For the coming 12 months, Clinigen Group is expected to pay a dividend of 0.54 GBP.

What is the dividend yield of Clinigen Group?

The current dividend yield of Clinigen Group is 0.82 %.

When does Clinigen Group pay dividends?

Clinigen Group pays a quarterly dividend. This is distributed in the months of April, December, April, January.

How secure is the dividend of Clinigen Group?

Clinigen Group paid dividends every year for the past 14 years.

What is the dividend of Clinigen Group?

For the upcoming 12 months, dividends amounting to 0.54 GBP are expected. This corresponds to a dividend yield of 5.87 %.

In which sector is Clinigen Group located?

Clinigen Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clinigen Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clinigen Group from 1/4/2022 amounting to 0.055 GBP, you needed to have the stock in your portfolio before the ex-date on 12/2/2021.

When did Clinigen Group pay the last dividend?

The last dividend was paid out on 1/4/2022.

What was the dividend of Clinigen Group in the year 2023?

In the year 2023, Clinigen Group distributed 0.514 GBP as dividends.

In which currency does Clinigen Group pay out the dividend?

The dividends of Clinigen Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Clinigen Group stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Clinigen Group

Our stock analysis for Clinigen Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clinigen Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.